Shane Ward
Chief Operating Officer at CIDARA THERAPEUTICS, INC.
Net worth: 66 794 $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jeffrey Stein | M | 69 | 10 years | |
| Hubert Allen | M | 58 | 18 years | |
| Daniel Burgess | M | 62 | 10 years | |
| Preetam Shah | M | 51 | 3 years | |
| Carin Canale-Theakston | F | 50 | 3 years | |
| Les Tari | M | 57 | 11 years | |
| Bonnie Bassler | M | 61 | 3 years | |
| David Novack | M | 62 | 11 years | |
| Chrysa Mineo | F | 59 | 6 years | |
| Theodore Schroeder | M | 69 | 10 years | |
| Taylor Sandison | M | 52 | 9 years | |
| Carmen Betancourt | F | - | 10 years | |
| Laura A. Navalta | F | - | 7 years | |
| John M. Capek | M | 62 | 18 years | |
| Todd Lopeman | M | - | 10 years | |
| Allison Lewis | F | - | 9 years | |
| Nicole Davarpanah | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Brett Pletcher | M | 56 | 17 years | |
| Alan Musso | M | 62 | 4 years | |
| Jeffrey L. Cleland | M | 59 |
Versartis, Inc.
 Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 7 years |
| Steven N. Gersten | M | - | - | |
| J. Tyler Martin | M | 64 | 4 years | |
| Joshua Brumm | M | 46 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 years |
| Mark Perry | M | 68 | 10 years | |
| George Morrow | M | 72 |
Human Genome Sciences, Inc.
 Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 1 years |
| Gregory Norden | M | 66 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 1 years |
| Laura Brege | F | 66 | 5 years | |
| Kevin Haas | M | 59 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 4 years |
| Frank B. McGuyer | M | 72 | 9 years | |
| Edmund Harrigan | M | 71 | 1 years | |
| Timothy Franson | M | 72 | 9 years | |
| David M. Spencer | M | 61 | 15 years | |
| Terrence Kearney | M | 69 | 25 years | |
| David Gollaher | M | 74 | 6 years | |
| Eddie J. Gray | M | 64 | 6 years | |
| Colin Hislop | M | 66 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | 1 years |
| Jennifer Lew | F | 51 | 9 years | |
| Sujata Dayal | F | 61 | 5 years | |
| Jessica Oien | F | 53 | 3 years | |
| Paul Daruwala | M | 55 | 8 years | |
| Dino Dina | M | 77 | 17 years | |
| Alan K. Smith | M | 68 | 5 years | |
| Barry A. Labinger | M | 60 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 7 years |
| Colin Goddard | M | 64 |
Human Genome Sciences, Inc.
Human Genome Sciences, Inc. Medical SpecialtiesHealth Technology Human Genome Sciences, Inc. is a biopharmaceutical company that exists to place new therapies into the hands of those battling serious disease. Its lead products include BENLYSTA for systemic lupus erythematosus and raxibacumab for inhalation anthrax. The firm's other products include, mapatumumab, darapladib, albiglutide, ZALBIN, HGS1036 and HGS1029. The company was founded by Alan G. Walton and William A. Haseltine in 1992 and is headquartered in Gaithersburg, MD. | 2 years |
| John Madigan | M | 86 | 12 years | |
| Nat Ricciardi | M | 75 | - | |
| Denise M. Gilbert | M | 66 | 11 years | |
| Nicholas G. Moore | M | 82 | - | |
| Kenneth Lee | M | 76 |
Versartis, Inc.
Versartis, Inc. Pharmaceuticals: MajorHealth Technology Versartis, Inc. is an endocrine-focused biopharmaceutical company, which engages in the research and development of pharmaceutical products. Its portfolio includes Somavartan and XTEN TEchnology which target the endocrine disorders and growth hormone deficiencies. The company was founded by Jeffrey L. Cleland, Mark de Boer, Willem Stemmer, Volker Schellenberger, and Joshua Silverman on December 10, 2008 and is headquartered in Menlo Park, CA. | - |
| John Francis Cogan | M | 76 | - | |
| Gary Winer | M | 64 | 6 years | |
| Perry Nisen | M | 68 | 7 years | |
| Patrick Taylor Horn | M | 69 | 5 years | |
| H. Watkins | M | 71 | 19 years | |
| Curtis Richard Jennewine | M | 56 | 3 years | |
| Chris M. Kolber | M | - | 14 years | |
| Nadine McCracken | F | - | 1 years | |
| Eric H. Sasso | M | - | - | |
| Richard W. Ashley | M | 79 | - | |
| Karen Hale | F | 56 | 6 years | |
| Hing Leung Sham | M | 71 | 23 years | |
| David Floyd | M | 63 | 2 years | |
| Peter Witty | M | 56 | 10 years | |
| Joseph M. Fortunak | M | 69 | 4 years | |
| Peter Heerma | M | 53 | 9 years | |
| Jose M. de Lasa | M | 82 | - | |
| Mark James Kontny | M | - | - | |
| Rita Jain | M | 62 | 9 years | |
| Michael Wheeler | M | - |
Sidley Austin LLP
 Sidley Austin LLP Miscellaneous Commercial ServicesCommercial Services Sidley Austin LLP is a premier legal adviser with over 2000 lawyers in 20 offices worldwide. Sidley Austin is based in Chicago, IL and has subsidiaries in Germany, Hong Kong, United States, United Kingdom, and Japan. The firm has been providing superior client service for over 150 years and has a diverse group of legal professionals from many cultures who are dedicated to teamwork and collaboration. Sidley Austin has forged enduring relationships with the business community and serves a varied and high-caliber group of market leaders, many of whom are pioneers in their respective industries and professions. The firm is committed to pro bono service and its lawyers and staff devote more than 100,000 hours annually to serving those most in need. | 6 years |
| Timi Edeki | M | - | 3 years | |
| Kelly Constable | F | - | 2 years | |
| Mike Ferry | M | - | 4 years | |
| Margo Heath-Chiozzi | M | 67 | 8 years | |
| Harold C. Flynn | M | 58 | 3 years | |
| William Daley | M | 75 | 7 years | |
| J. White | M | 56 | - | |
| Jane Wright-Mitchell | F | 55 | 2 years | |
| Bruce G. McCarthy | M | - | 7 years | |
| Gary McCullough | M | 65 | 4 years | |
| Alejandro A. Aruffo | M | 63 | 3 years | |
| Jeffrey Binder | M | 60 | 1 years | |
| Olivier Jean Bohuon | M | 65 | 7 years | |
| Karen L. Miller | F | 69 | - | |
| Donald V. Patton | M | 71 | - | |
| Karl G. Trass | M | 64 | - | |
| Jeff Smith | M | 64 | 5 years | |
| David A. Wardell | M | 69 | - | |
| Steven Fife | M | 65 | 1 years | |
| John M. Taylor | M | 59 | 2 years | |
| A. David Forrest | M | 62 | - | |
| Manuel Méndez Muñiz | M | 56 | 2 years | |
| Brian Joseph Smith | M | 72 | 25 years | |
| Lamont Robinson | M | - | 4 years | |
| Shi-Chung Ng | M | 69 | 11 years | |
| Paul A. Arrendell | M | 58 | 6 years | |
| Andrew Allen | M | 57 | 2 years | |
| Timothy Walbert | M | 57 | 4 years | |
| Joseph Stauffer | M | 58 | 2 years | |
| Christopher Begley | M | 71 | 18 years | |
| Perry Siatis | M | - | 8 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 100 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Shane Ward
- Personal Network
